source
- Generate:Biomedicines shares early Phase 1 respiratory data after ERS poster leakGenerate:Biomedicines presented Phase 1 data for its respiratory disease candidate at the European Respiratory Society annual meeting. The presentation came after the conference posters were releas…
- Experts discuss hurdles and prospects for the first approved Fragile X therapyIn a recent episode of BioSpace's "Denatured" podcast, Hilary Rosselot of the National Fragile X Foundation and Jordi Fàbrega, co‑founder and CEO of CONNECTA Therapeutics, talked about the current…